Zobrazeno 1 - 10
of 52
pro vyhledávání: '"Jan van Meerbeeck"'
Autor:
Suzanne Wait, PhD, Arturo Alvarez-Rosete, PhD, Tasnime Osama, MD, Dani Bancroft, MSc, Robin Cornelissen, PhD, Ante Marušić, PhD, Pilar Garrido, PhD, Mariusz Adamek, PhD, Jan van Meerbeeck, PhD, Annemiek Snoeckx, PhD, Olivier Leleu, MD, Ebba Hallersjö Hult, BSc, Sébastien Couraud, PhD, David R. Baldwin, MD
Publikováno v:
JTO Clinical and Research Reports, Vol 3, Iss 5, Pp 100329- (2022)
Lung cancer is the leading cause of cancer death in Europe. Screening by means of low-dose computed tomography (LDCT) can shift detection to an earlier stage and reduce lung cancer mortality in high-risk individuals. However, to date, Poland, Croatia
Externí odkaz:
https://doaj.org/article/7e2c243ec26b4629ae48ff6790d1cb01
Autor:
Wouter H. van Geffen, Torsten G. Blum, Stefano Aliberti, Kevin G. Blyth, Clementine Bostantzoglou, Amy Farr, Bogdan Grigoriu, Georgia Hardavella, Rudolf M. Huber, Nick Maskell, Gilbert Massard, Najib M. Rahman, Daiana Stolz, Jan van Meerbeeck
Publikováno v:
Breathe, Vol 15, Iss 4, Pp 279-285 (2019)
Externí odkaz:
https://doaj.org/article/08e2f690cbac421f9473c6607c466124
Autor:
Denis Horgan, Giuseppe Curigliano, Olaf Rieß, Paul Hofman, Reinhard Büttner, Pierfranco Conte, Tanja Cufer, William M. Gallagher, Nadia Georges, Keith Kerr, Frédérique Penault-Llorca, Ken Mastris, Carla Pinto, Jan Van Meerbeeck, Elisabetta Munzone, Marlene Thomas, Sonia Ujupan, Gilad W. Vainer, Janna-Lisa Velthaus, Fabrice André
Publikováno v:
Journal of Personalized Medicine, Vol 12, Iss 1, p 72 (2022)
Next-generation sequencing (NGS) may enable more focused and highly personalized cancer treatment, with the National Comprehensive Cancer Network and European Society for Medical Oncology guidelines now recommending NGS for daily clinical practice fo
Externí odkaz:
https://doaj.org/article/fcb15b6b903b4209b177bb4be9df6b34
Autor:
Wouter H. van Geffen, Kevin Lamote, Adrien Costantini, Lizza E.L. Hendriks, Najib M. Rahman, Torsten G. Blum, Jan van Meerbeeck
Publikováno v:
Breathe, Vol 15, Iss 4, Pp e135-e141 (2019)
Lung cancer is very common and the most common cause of cancer death worldwide. Despite recent progress in the systemic treatment of lung cancer (checkpoint inhibitors and tyrosine kinase inhibitors), each year, >1.5 million people die due to this di
Externí odkaz:
https://doaj.org/article/3a70ff6772984854a0bc3c284d3c00be
Autor:
Denis Horgan, Gennaro Ciliberto, Pierfranco Conte, Giuseppe Curigliano, Luis Seijo, Luis M. Montuenga, Marina Garassino, Frederique Penault-Llorca, Fabrizia Galli, Isabelle Ray-Coquard, Denis Querleu, Peter Riegman, Keith Kerr, Hein Van Poppel, Anders Bjartell, Giovanni Codacci-Pisanelli, Jasmina Koeva-Balabanova, Angelo Paradiso, Zorana Maravic, Vassiliki Fotaki, Nuria Malats, Chiara Bernini, Simonetta Buglioni, Alastair Kent, Elisabetta Munzone, Ivica Belina, Jan Van Meerbeeck, Michael Duffy, Beata Jagielska, Ettore Capoluongo
Publikováno v:
Cancers, Vol 13, Iss 3, p 583 (2021)
Rapid and continuing advances in biomarker testing are not being matched by uptake in health systems, and this is hampering both patient care and innovation. It also risks costing health systems the opportunity to make their services more efficient a
Externí odkaz:
https://doaj.org/article/74b76549363c4c63953a57c663011df2
Autor:
Denis Horgan, Gennaro Ciliberto, Pierfranco Conte, David Baldwin, Luis Seijo, Luis M. Montuenga, Luis Paz-Ares, Marina Garassino, Frederique Penault-Llorca, Fabrizia Galli, Isabelle Ray-Coquard, Denis Querleu, Ettore Capoluongo, Susana Banerjee, Peter Riegman, Keith Kerr, Benjamin Horbach, Reinhard Büttner, Hein Van Poppel, Anders Bjartell, Giovanni Codacci-Pisanelli, Benedikt Westphalen, Fabien Calvo, Jasmina Koeva-Balabanova, Stephen Hall, Angelo Paradiso, Dipak Kalra, Christa Cobbaert, Rocio Varea Menendez, Zorana Maravic, Vassiliki Fotaki, Jaafar Bennouna, Estelle Cauchin, Nuria Malats, Iñaki Gutiérrez-Ibarluzea, Benjamin Gannon, Ken Mastris, Chiara Bernini, William Gallagher, Simonetta Buglioni, Alastair Kent, Elisabetta Munzone, Ivica Belina, Jan Van Meerbeeck, Michael Duffy, Elżbieta Sarnowska, Beata Jagielska, Sarah Mee, Giuseppe Curigliano
Publikováno v:
Biomedicine Hub, Vol 5, Iss 3, Pp 1-1 (2020)
Rapid and continuing advances in biomarker testing are not being matched by take-up in health systems, and this is hampering both patient care and innovation. It also risks costing health systems the opportunity to make their services more efficient
Externí odkaz:
https://doaj.org/article/23c9748ba2f5428dbcd608ea1ef409ad
Autor:
Laure Sorber, Karen Zwaenepoel, Julie Jacobs, Koen De Winne, Sofie Goethals, Pablo Reclusa, Kaat Van Casteren, Elien Augustus, Filip Lardon, Geert Roeyen, Marc Peeters, Jan Van Meerbeeck, Christian Rolfo, Patrick Pauwels
Publikováno v:
Cancers, Vol 11, Iss 4, p 458 (2019)
The combined analysis of circulating cell-free (tumor) DNA (cfDNA/ctDNA) and circulating cell-free (tumor) RNA (cfRNA/ctRNA) shows great promise in determining the molecular profile of cancer patients. Optimization of the workflow is necessary to ach
Externí odkaz:
https://doaj.org/article/0012f707ac684910bdfabb0f54feef2f
Autor:
Jacques De Grève, Jan Van Meerbeeck, Johan F Vansteenkiste, Lore Decoster, Anne-Pascale Meert, Peter Vuylsteke, Christian Focan, Jean-Luc Canon, Yves Humblet, Guy Berchem, Benoit Colinet, Danny Galdermans, Lionel Bosquée, Joanna Vermeij, Alex Dewaele, Caroline Geers, Denis Schallier, Erik Teugels
Publikováno v:
PLoS ONE, Vol 11, Iss 3, p e0147599 (2016)
INTRODUCTION:Epidermal Growth Factor Receptor (EGFR) tyrosine kinase inhibition is the preferred first-line treatment of advanced adenocarcinoma of the lung that harbors EGFR activating tyrosine kinase domain mutations. Most data available pertain to
Externí odkaz:
https://doaj.org/article/d77d90c2874a41ca9219fe0d09d1012a
Autor:
Dori GIROUX, Jan Van MEERBEECK, John J. CROWLEY, Jean-Paul SCULIER, Kari CHANSKY, Peter GOLDSTRAW
Publikováno v:
Chinese Journal of Lung Cancer, Vol 13, Iss 1, Pp 9-18 (2010)
Externí odkaz:
https://doaj.org/article/8a895009d88748928658d5022bba6504
Autor:
Hisao Asamura, Katherine K. Nishimura, Dorothy J. Giroux, Kari Chansky, Antje Hoering, Valerie Rusch, Ramón Rami-Porta, Luiz Henrique Araujo, David Beer, Pietro Bertoglio, Ricardo Beyruti, Andrea Billè, Souheil Boubia, Elisabeth Brambilla, A.K. Cangir, David Carbone, Vanessa Cilento, Casey Connolly, Gail Darling, Frank Detterbeck, Daniel Dibaba, Xavier Benoit D’Journo, Jessica Donington, Wilfried Eberhardt, John Edwards, Jeremy Erasmus, Wentao Fang, Dean Fennell, Kwun Fong, Françoise Galateau-Sallé, Oliver Gautschi, Ritu R. Gill, Dorothy Giroux, Meredith Giuliani, Jin Mo Goo, Seiki Hasegawa, Fred Hirsch, Hans Hoffman, Wayne Hofstetter, James Huang, Philippe Joubert, Kemp Kernstine, Keith Kerr, Young Tae Kim, Dong Kwan Kim, Hedy Kindler, Yolande Lievens, Hui Liu, Donald E. Low, Gustavo Lyons, Heber MacMahon, Alyson Mahar, Mirella Marino, Edith M. Marom, José-María Matilla, Jan van Meerbeeck, Luis M. Montuenga, Andrew Nicholson, Katie Nishimura, Anna Nowak, Isabelle Opitz, Meinoshin Okumura, Raymond U. Osarogiagbon, Harvey Pass, Marc de Perrot, Helmut Prosch, David Rice, Andreas Rimner, Adam Rosenthal, Enrico Ruffini, Shuji Sakai, Paul Van Schil, Navneet Singh, Francisco Suárez, Ricardo M. Terra, William D. Travis, Ming S. Tsao, Paula Ugalde, Shun-ichi Watanabe, Ignacio Wistuba, Murry Wynes, Yasushi Yatabe
Publikováno v:
Journal of Thoracic Oncology. 18:564-575